SafetyMargin.ioSafetyMargin.io
BlogWatchlistCompare
Compare Stocks › ABBV vs ZBRA

AbbVie Inc. (ABBV) vs Zebra Technologies Corporation (ZBRA): Which Is the Better Buy in 2026?

As of 2026-06-19, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. ZBRA is fairly valued at $236, with an intrinsic value of $237 and a margin of safety of 0%. Of the two, ZBRA has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
ZBRA
Zebra Technologies Corporation
$235.98

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
ZBRA
  • ★Zebra Technologies Corporation scores 74/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • ★Free cash flow has grown at a 26.2% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • ★Trailing P/E of 28.5x is 21% below the historical average of 35.9x — potentially undervalued relative to its own history.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • ⚠Trailing P/E of 105.6x is 69% above the historical average of 62.3x — the stock trades at a premium to its own history.
ZBRA
  • ⚠ROIC has declined by 6.6 percentage points over the past 4 years, which may signal competitive erosion.
  • ⚠FCF yield of 7.4% suggests reasonable valuation assuming continued moderate growth.

Key Valuation Metrics

Learn more →
ABBV
ZBRA
Valuation
$20.81B
Free Cash Flow
$831.00M
5.44%
FCF Yield
7.39%
105.60
Trailing P/E
28.47
13.32
Forward P/E
11.40
Quality & Moat
21.89%
ROIC
10.46%
N/A
ROE
11.78%
72.03%
Gross Margin
48.18%
0.61
PEG Ratio
0.51
Balance Sheet Safety
N/A
Net Debt / Equity
0.79
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
2.67
3.11%
Dividend Yield
0.00%
ABBV: 5Ties: 1ZBRA: 4
ABBVZBRA

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

ZBRA

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
ZBRA
$-0.93
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$1.24B
Δ Market Cap
$-1.15B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
ZBRA
0.4% Margin of Safety
Price is 0.4% below estimated fair value
Current Price: $235.98
Fair Value: $236.81
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

ZBRA

What growth rate is the market pricing in at $236?

+11.8%
Market-Implied Owner Earnings Growth
Standard FCF implies +5.3%

The market implies +11.8% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +5.3%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
ZBRA
74/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by roic consistency. Revenue Predictability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
ZBRA
-2.58
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,106
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
ZBRA
Insiders 0.8%Institutions 103.4%
No. of Institutional Holders971
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
ZBRA
0
Buys (3M)
3
Buys (12M)
Total value (12M): $386,823
DHANASEKARAN SATISH
Director
$41,080
@ $205.40 · 2026-03-12
DHANASEKARAN SATISH
Director
$112,625
@ $225.25 · 2026-02-27
DHANASEKARAN SATISH
Director
$233,118
@ $233.12 · 2025-11-18
GUSTAFSSON PER ANDERS
Director
$1.00M
@ $309.96 · 2025-02-25
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
ZBRA
1
Sells (3M)
4
Sells (12M)
Total value (12M): $1.14M
ROBERTS JANICE M
Director
$748,620
@ $249.54 · 2026-05-14
KOGL CRISTEN L
Officer
$34,178
@ $235.71 · 2026-03-05
ARMSTRONG ROBERT JOHN JR
Officer
$2,068
@ $229.78 · 2026-03-05
CONNLY LINDA
Director
$356,454
@ $322.00 · 2025-08-12
O SULLIVAN COLLEEN M
Officer
$75,979
@ $399.89 · 2024-11-25
CHO MICHAEL
Officer
$119,483
@ $400.95 · 2024-11-12
WHITE JOSEPH RAMSEY
Officer
$623,567
@ $400.75 · 2024-11-08
HUDSON RICHARD EDWARD
Officer
$435,889
@ $394.47 · 2024-11-07
SCHMITZ JEFFREY F
Officer
$266,098
@ $387.33 · 2024-11-06
KOGL CRISTEN L
Officer
$203,580
@ $390.00 · 2024-11-06
ARMSTRONG ROBERT JOHN JR
Officer
$359,317
@ $393.13 · 2024-11-06
WINTERS NATHAN ANDREW
Chief Financial Officer
$701,241
@ $381.73 · 2024-10-31
SCHMITZ JEFFREY F
Officer
$341,690
@ $341.69 · 2024-08-15
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
ZBRA
FearGreed
😨Fear(30/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
ZBRA
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (30)
View ABBV Full AnalysisView ZBRA Full Analysis

Frequently Asked Questions: ABBV vs ZBRA

Is AbbVie Inc. or Zebra Technologies Corporation more undervalued in 2026?▼

Based on our discounted cash flow model, ZBRA trades at a 0.4% margin of safety (intrinsic value $237 vs. price $236), compared to ABBV's -35.3% margin of safety (intrinsic $160 vs. $216).

Which stock has a wider economic moat, AbbVie Inc. or Zebra Technologies Corporation?▼

ABBV scores 82/100 (Wide moat), while ZBRA scores 74/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?▼

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. ZBRA scores 3.3 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, AbbVie Inc. or Zebra Technologies Corporation?▼

Zebra Technologies Corporation (ZBRA) generates a 7.4% free cash flow yield, compared to AbbVie Inc.'s 5.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or Zebra Technologies Corporation?▼

ABBV earns 21.9% ROIC versus ZBRA's 10.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.